Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma

Xin Li Zhu, Warren Hartwick, Thomas E. Rohan, Rita Kandel

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Cyclin D1 plays a critical role in regulating cell-cycle progression. Gene amplification and protein overexpression of cyclin D1 have been detected in breast cancer but little is known concerning whether these changes occur in normal breast tissue and in breast lesions associated with increased risk of development of invasive breast cancer. We looked for cyclin D1 gene amplification and protein overexpression in 30 cases of benign breast disease (16 epithelial hyperplasias without atypia and 14 atypical ductal hyperplasias) and 18 ductal carcinomas in situ by use of differential PCR and immunohistochemical staining. We compared the resulting frequencies to those in 15 cases of normal breast tissue and 17 invasive ductal carcinomas. We found cyclin D1 gene amplification in 15% of those with normal breast tissue, 19% of those with epithelial hyperplasia without atypia, 27% of those with atypical ductal hyperplasia, 35% of those with ductal carcinoma in situ, and 25% of those with invasive ductal carcinoma; corresponding figures for protein overexpression were 13, 13, 57, 50, and 64%. These results suggest that cyclin D1 amplification and protein overexpression can occur before histologic alterations are seen but that the frequencies of these changes are higher in histologic lesions with cellular atypia (atypical hyperplasia and ductal carcinoma in situ), reaching frequencies similar to those observed in invasive carcinoma.

Original languageEnglish (US)
Pages (from-to)1082-1088
Number of pages7
JournalModern Pathology
Volume11
Issue number11
StatePublished - Nov 1998
Externally publishedYes

Fingerprint

bcl-1 Genes
Breast Diseases
Carcinoma, Intraductal, Noninfiltrating
Gene Amplification
Breast Neoplasms
Cyclin D1
Breast
Hyperplasia
Ductal Carcinoma
Proteins
Cell Cycle
Staining and Labeling
Carcinoma
Polymerase Chain Reaction

Keywords

  • Benign breast disease
  • Cyclin D1
  • Differential polymerase chain reaction
  • Immunohistochemistry

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. / Zhu, Xin Li; Hartwick, Warren; Rohan, Thomas E.; Kandel, Rita.

In: Modern Pathology, Vol. 11, No. 11, 11.1998, p. 1082-1088.

Research output: Contribution to journalArticle

Zhu, Xin Li ; Hartwick, Warren ; Rohan, Thomas E. ; Kandel, Rita. / Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. In: Modern Pathology. 1998 ; Vol. 11, No. 11. pp. 1082-1088.
@article{deefc2220a09461989dbafe45b7cd132,
title = "Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma",
abstract = "Cyclin D1 plays a critical role in regulating cell-cycle progression. Gene amplification and protein overexpression of cyclin D1 have been detected in breast cancer but little is known concerning whether these changes occur in normal breast tissue and in breast lesions associated with increased risk of development of invasive breast cancer. We looked for cyclin D1 gene amplification and protein overexpression in 30 cases of benign breast disease (16 epithelial hyperplasias without atypia and 14 atypical ductal hyperplasias) and 18 ductal carcinomas in situ by use of differential PCR and immunohistochemical staining. We compared the resulting frequencies to those in 15 cases of normal breast tissue and 17 invasive ductal carcinomas. We found cyclin D1 gene amplification in 15{\%} of those with normal breast tissue, 19{\%} of those with epithelial hyperplasia without atypia, 27{\%} of those with atypical ductal hyperplasia, 35{\%} of those with ductal carcinoma in situ, and 25{\%} of those with invasive ductal carcinoma; corresponding figures for protein overexpression were 13, 13, 57, 50, and 64{\%}. These results suggest that cyclin D1 amplification and protein overexpression can occur before histologic alterations are seen but that the frequencies of these changes are higher in histologic lesions with cellular atypia (atypical hyperplasia and ductal carcinoma in situ), reaching frequencies similar to those observed in invasive carcinoma.",
keywords = "Benign breast disease, Cyclin D1, Differential polymerase chain reaction, Immunohistochemistry",
author = "Zhu, {Xin Li} and Warren Hartwick and Rohan, {Thomas E.} and Rita Kandel",
year = "1998",
month = "11",
language = "English (US)",
volume = "11",
pages = "1082--1088",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma

AU - Zhu, Xin Li

AU - Hartwick, Warren

AU - Rohan, Thomas E.

AU - Kandel, Rita

PY - 1998/11

Y1 - 1998/11

N2 - Cyclin D1 plays a critical role in regulating cell-cycle progression. Gene amplification and protein overexpression of cyclin D1 have been detected in breast cancer but little is known concerning whether these changes occur in normal breast tissue and in breast lesions associated with increased risk of development of invasive breast cancer. We looked for cyclin D1 gene amplification and protein overexpression in 30 cases of benign breast disease (16 epithelial hyperplasias without atypia and 14 atypical ductal hyperplasias) and 18 ductal carcinomas in situ by use of differential PCR and immunohistochemical staining. We compared the resulting frequencies to those in 15 cases of normal breast tissue and 17 invasive ductal carcinomas. We found cyclin D1 gene amplification in 15% of those with normal breast tissue, 19% of those with epithelial hyperplasia without atypia, 27% of those with atypical ductal hyperplasia, 35% of those with ductal carcinoma in situ, and 25% of those with invasive ductal carcinoma; corresponding figures for protein overexpression were 13, 13, 57, 50, and 64%. These results suggest that cyclin D1 amplification and protein overexpression can occur before histologic alterations are seen but that the frequencies of these changes are higher in histologic lesions with cellular atypia (atypical hyperplasia and ductal carcinoma in situ), reaching frequencies similar to those observed in invasive carcinoma.

AB - Cyclin D1 plays a critical role in regulating cell-cycle progression. Gene amplification and protein overexpression of cyclin D1 have been detected in breast cancer but little is known concerning whether these changes occur in normal breast tissue and in breast lesions associated with increased risk of development of invasive breast cancer. We looked for cyclin D1 gene amplification and protein overexpression in 30 cases of benign breast disease (16 epithelial hyperplasias without atypia and 14 atypical ductal hyperplasias) and 18 ductal carcinomas in situ by use of differential PCR and immunohistochemical staining. We compared the resulting frequencies to those in 15 cases of normal breast tissue and 17 invasive ductal carcinomas. We found cyclin D1 gene amplification in 15% of those with normal breast tissue, 19% of those with epithelial hyperplasia without atypia, 27% of those with atypical ductal hyperplasia, 35% of those with ductal carcinoma in situ, and 25% of those with invasive ductal carcinoma; corresponding figures for protein overexpression were 13, 13, 57, 50, and 64%. These results suggest that cyclin D1 amplification and protein overexpression can occur before histologic alterations are seen but that the frequencies of these changes are higher in histologic lesions with cellular atypia (atypical hyperplasia and ductal carcinoma in situ), reaching frequencies similar to those observed in invasive carcinoma.

KW - Benign breast disease

KW - Cyclin D1

KW - Differential polymerase chain reaction

KW - Immunohistochemistry

UR - http://www.scopus.com/inward/record.url?scp=0008715196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0008715196&partnerID=8YFLogxK

M3 - Article

C2 - 9831206

AN - SCOPUS:0008715196

VL - 11

SP - 1082

EP - 1088

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 11

ER -